Insider · CIK 0002089213
Nikunj Jain
officer
Files at SGMOQ (SANGAMO THERAPEUTICS, INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -666 | $0.47 | $315 | 242,330 | Feb 26, 2026 |
| Feb 25, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -5,119 | $0.47 | $2,406 | 237,211 | Feb 26, 2026 |
| Jan 22, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -7,721 | $0.40 | $3,077 | 242,996 | Jan 26, 2026 |
| Nov 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -578 | $0.42 | $241 | 245,717 | Nov 26, 2025 |
| Oct 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -6,708 | $0.66 | $4,427 | 246,295 | Oct 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.